Statistical analysis
The sample size was calculated to detect a difference in ESSDAI response rates between treatment arms in the range of 25–33% (two-sided χThe proportion of patients who had ≥3-point reduction from baseline in ESSDAI score after 12 weeks of treatment were compared between the two treatment arms using a Pearson χAll patients who received at least one dose of the study medication were included in the safety analysis population.